ZRANB3 and endometrial carcinoma: Finally, our structural and biochemical findings allowed us to interpret the functional significance of cancer associated variants in ZRANB3. We analysed ZRANB3 mutations associated with endometrial carcinomas and noted a high incidence of mutations predicted to yield functionally deficient proteins (Supplementary Table 2 and Fig. 8).